Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Phenylboronic acid modified polyethyleneimine alginate chitosan dynamic hydrogels combination with adipose derived stem cells for controlled delivery of BMP2 to promote bone regeneration and modulating macrophage and ang

Wang H., Zhao Z., Mou L., Li S., Jia X., Dong Y.

Animal Study on Immune Modulation, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40972920
DOI
10.1016/j.ijbiomac.2025.147767
Citations
2

Abstract (original English)

Bone morphogenetic protein-2 (BMP2) has been approved by the United States Food and Drug Administration (FDA) to be used in human lumbar fusion to promote bone regeneration. However, BMP2 has a short half-life, rapid degradation, and burst release at high concentrations, which aggravates its adverse effects. A sodium alginate chitosan PEI-PBA-BMP2-ADSCs (SCPPBA) hydrogel was constructed. Hydrogel structure, biocompatibility, osteoinductivity, immunoregulation, and angiogenesis were evaluated. The SCPPBA hydrogel exhibited a porous structure, chemical crosslinking, moderate elastic modulus and viscosity, biocompatibility, biodegradation, and controlled and long-period BMP2 protein release. In an in vitro study, SCPPBA hydrogel exhibited osteoinductivity and immune modulation. We further implanted the SCPPBA hydrogel into a calvarial bone defect model in mice. The SCPPBA hydrogel exhibited excellent bone regeneration capacity and modulated macrophage polarization and angiogenesis in vivo. The SCPPBA hydrogel realizes the long-term controlled delivery of BMP2 and is suitable for BMP2 loaded implantation to promote bone regeneration.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone Morphogenetic Protein 2Bone RegenerationHydrogelsAnimalsChitosanAlginatesMiceMacrophagesNeovascularization, PhysiologicPolyethyleneimine

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research